Syra Health Corp (NASDAQ:SYRA) currently has a daily average trading volume of 935.98K but it saw 1580741 shares traded in last market. With a market cap of 1.51M USD, the company’s current market price of $0.13 came falling about -37.94 while comparing to the previous closing price of $0.20. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.27 and as low as $0.13. In the recent trading on the day, stock has struck highest price mark of $0.1013 while lowest mark touched by it was $0.18.
Taking a look at 20-day trading activity of Syra Health Corp (SYRA) gives us an average price of $0.2440, while its current price level is -94.40% below from 52-week high level whereas it is -2.68% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3296 while that of 200 days or SMA-200 reads an average of $0.6062. A closer look into the stock’s movement over the week reveals that its volatility is standing at 30.23% during that period while stretching the period over a month that decreases to 21.69%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 25.40 which implies that the stock is in oversold territory.
Over the week, SYRA’s stock price is moving -46.57% down while it is -61.48% when we observe its performance for the past one month. Year-to-date it is -69.14% down and over the past year, the stock is showing a downside performance of -89.67%.
The company is expected to be releasing its next quarterly report on 2024-Oct-28, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Syra Health Corp’s total number of outstanding shares is 11.91M with 14.59% of that held by the insiders while 5.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -122.62% and return on equity (ROE) at -109.09%. Stock’s beta reads 3.95. Stock has a price to book (P/B) ratio of 0.43 while price to sale or P/S ratio amounts to 0.19. Its return on asset (ROA) is -87.40% on average.
